Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Garrido

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 7, 2018
Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative ChemotherapyDouglas S Swords, Samual R Francis, Shane Lloyd, et al.
Cancers|April 13, 2024
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic CancerFaithlore P Gardner, Zev A Wainberg, Christos Fountzilas, et al.
The Science of the Total Environment|June 18, 2024
Diverse inorganic carbon uptake strategies in Antarctic seaweeds: Revealing species-specific responses and implications for Ocean AcidificationPamela A Fernández, Charles D Amsler, Catriona L Hurd, et al.
Plos One|February 22, 2020
The stochastic nature of errors in next-generation sequencing of circulating cell-free DNADavid A Nix, Sabine Hellwig, Christopher Conley, et al.
Cancer Research|April 5, 2011
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasionBéatrice Dirat, Ludivine Bochet, Marta Dabek, et al.
Immunotherapy|September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumorsBen Tran, Mark Voskoboynik, Johanna Bendell, et al.
Molecular Cancer Therapeutics|December 8, 2010
Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancerMaria C Villarroel, N V Rajeshkumar, Ignacio Garrido-Laguna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 29, 2014
Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in UtahN Jewel Samadder, Karen Curtin, Jathine Wong, et al.
Neoplasia (New York, N.Y.)|July 23, 2021
Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinomaKajsa E Affolter, Sabine Hellwig, David A Nix, et al.
Frontiers in Immunology|May 2, 2022
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid TumorsJames J Harding, Ignacio Garrido-Laguna, Xiaoying Chen, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 7, 2018
Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative ChemotherapyDouglas S Swords, Samual R Francis, Shane Lloyd, et al.
Cancers|April 13, 2024
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic CancerFaithlore P Gardner, Zev A Wainberg, Christos Fountzilas, et al.
The Science of the Total Environment|June 18, 2024
Diverse inorganic carbon uptake strategies in Antarctic seaweeds: Revealing species-specific responses and implications for Ocean AcidificationPamela A Fernández, Charles D Amsler, Catriona L Hurd, et al.
Plos One|February 22, 2020
The stochastic nature of errors in next-generation sequencing of circulating cell-free DNADavid A Nix, Sabine Hellwig, Christopher Conley, et al.
Cancer Research|April 5, 2011
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasionBéatrice Dirat, Ludivine Bochet, Marta Dabek, et al.
Immunotherapy|September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumorsBen Tran, Mark Voskoboynik, Johanna Bendell, et al.
Molecular Cancer Therapeutics|December 8, 2010
Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancerMaria C Villarroel, N V Rajeshkumar, Ignacio Garrido-Laguna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 29, 2014
Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in UtahN Jewel Samadder, Karen Curtin, Jathine Wong, et al.
Neoplasia (New York, N.Y.)|July 23, 2021
Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinomaKajsa E Affolter, Sabine Hellwig, David A Nix, et al.
Frontiers in Immunology|May 2, 2022
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid TumorsJames J Harding, Ignacio Garrido-Laguna, Xiaoying Chen, et al.
Pageof 19